Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study
- DOI
- 10.1016/j.ejca.2025.116201
- Published
- 2026-02
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2025.116201,
title = {Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study},
author = {Hildur Helgadottir and Lars Ny and Gustav J. Ullenhag and Rasmus Mikiver and Karolin Isaksson and Roger Olofsson Bagge},
year = {2026},
journal = {European Journal of Cancer},
doi = {10.1016/j.ejca.2025.116201},
url = {https://doi.org/10.1016/j.ejca.2025.116201}
}RIS
TY - JOUR TI - Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study AU - Hildur Helgadottir AU - Lars Ny AU - Gustav J. Ullenhag AU - Rasmus Mikiver AU - Karolin Isaksson AU - Roger Olofsson Bagge PY - 2026 JO - European Journal of Cancer DO - 10.1016/j.ejca.2025.116201 UR - https://doi.org/10.1016/j.ejca.2025.116201 ER -
APA
Helgadottir, H., Ny, L., Ullenhag, G. J., Mikiver, R., Isaksson, K., & Bagge, R. O. (2026). Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116201
Source records
- crossref · retrieved 2026-09-27T00:12:25.845Z